Search for: "Harris v. Eli Lilly and Company"
Results 1 - 20
of 25
Sort by Relevance
|
Sort by Date
7 Feb 2023, 12:00 pm
Harris County, 529 U.S. 576, 587 (2000)). [read post]
19 Dec 2019, 9:41 am
In his reference, the Judge trotted through the English court's and CJEU's case law Article 3(a) - Takeda, Farmitalia, Daiichi, Yeda, Medeva (and its progeny), Actavis v Sanofi, Eli Lilly v HGS, Actavis v Boehringer, - and found that it was clear that something more was required, but what that "something" was was not clear. [read post]
18 Apr 2017, 6:52 am
Eli Lilly & Co., 598 F.3d 1336, 1352-53 (Fed. [read post]
11 Apr 2017, 3:01 pm
CSR now encompasses not only what companies do with their profits, but also how they make them in virtually every respect of their operations. [read post]
9 May 2016, 4:00 am
Eli Lilly and Co., 2004 FCA 232 at para 15) Much of the commentary on these new guidelines have focused on their application to pharmaceuticals. [read post]
26 May 2015, 7:42 am
SJS/TEN is somewhat analogous in our sandbox to mesothelioma in asbestos cases, since plaintiffs often work backwards from the diagnosis to look for some drug company to sue. [read post]
2 Aug 2014, 6:05 am
Niven v. [read post]
30 Nov 2012, 8:19 am
(Omega AG) (Omega Ltd.) [2012] EWHC 3440 (Ch) (30 November 2012) Cometson & Anor v Merthyr Tydfil County Borough Council & Anor [2012] EWHC 3446 (Ch) (30 November 2012) High Court (Patents Court) Actavis Group HF v Eli Lilly & Company [2012] EWHC 3316 (Pat) (27 November 2012) High Court (Queen’s Bench Division) Hussain v King Edward VII Hospital [2012] EWHC 3441 (QB) (30 November 2012) O’Dwyer v ITV Plc [2012]… [read post]
10 May 2012, 9:22 am
Eli Lily & Company, in which it held that pharmaceutical reps are exempt under the FLSA's administrative exemption. [read post]
28 Oct 2011, 7:00 am
Eli Lilly & Co., 2009 WL 5216930, at *12 (E.D.N.Y. [read post]
2 Jun 2011, 12:46 pm
Nail v. [read post]
19 Feb 2011, 3:32 pm
The subsequent case of Harris Corp. v. [read post]
29 Apr 2010, 4:09 pm
Bradford Company v. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
2 Jul 2009, 5:18 am
App. 1988); Harris v. [read post]
20 Mar 2009, 2:05 am
Eli Lilly & Co., 774 F.2d 830, 835 (7th Cir. 1985); Martinkovic v. [read post]
29 Aug 2008, 1:25 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC sets strict standards to establish inequitable conduct: Star Scientific v R J Reynolds Tobacco: (Hal Wegner), (Maryland Intellectual Property Law Blog), (Patent Prospector), (Patent Docs), (Patently-O), (more from Patently-O), (Philip Brooks), (Law360), (I/P Updates), Safe harbour ruling in Io v Veoh could help YouTube in Viacom… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human… [read post]
4 Aug 2008, 10:57 am
Court of Appeal (Criminal Division) Laku, R v [2008] EWCA Crim 1745 (16 July 2008) Wilson, R v [2008] EWCA Crim 1754 (15 July 2008) Sivaraman, R. v [2008] EWCA Crim 1736 (24 July 2008) Islam, R v [2008] EWCA Crim 1740 (31 July 2008) Court of Appeal (Civil Division) Perry & Anor v Harris (A Minor) [2008] EWCA Civ 907 (31 July 2008) Jirehouse Capital & Anor v Beller & Anor [2008] EWCA Civ 908 (30 July 2008)… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
